Physician profile
Thomas E Mccullough
NPI 1093980757
$3,918.66
in general payments reported to CMS, 2019-2025
43 companies · $513 in 2025
The $513 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $304 · 2021: $729 · 2022: $537 · 2023: $663 · 2024: $809 · 2025: $513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,986.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,986.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $616.31 | 2020-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $490.63 | 2019-2025 | Mounjaro, Zepbound |
| Abbvie INC. | $478.42 | 2021-2025 | |
| Novo Nordisk INC | $318.72 | 2019-2025 | Ozempic, Rybelsus |
| Amarin Pharma, INC. | $170.83 | 2019-2021 | |
| Emd Serono, INC. | $143.31 | 2019 | |
| Pfizer INC. | $128.22 | 2019-2023 | |
| Boston Scientific Corporation | $126.84 | 2020-2025 | Watchman Flx, Watchman Access System |
| Novartis Pharmaceuticals Corporation | $122.98 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $113.30 | 2019-2022 | |
| Daiichi Sankyo INC. | $112.96 | 2021-2023 | Injectafer |
| Janssen Pharmaceuticals, INC | $103.79 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $102.37 | 2022-2025 | Jardiance |
| Abbott Laboratories | $100.66 | 2021-2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $97.34 | 2021-2024 | Trelegy Ellipta, Arexvy |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $53.35 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Idorsia Pharmaceuticals US INC | $51.58 | 2022-2024 | Quviviq |
| E.R. Squibb & Sons, L.L.C. | $40.34 | 2021-2023 | Eliquis |
| Genentech USA, INC. | $36.25 | 2020-2022 | |
| Xeris Pharmaceuticals, INC. | $33.54 | 2021-2024 | Gvoke Hypopen |
| Kyowa Kirin, INC. | $29.60 | 2024 | Crysvita |
| Allergan, INC. | $29.32 | 2019-2020 | |
| Stryker Corporation | $28.94 | 2025 | Clottriever Bold Catheter |
| Lundbeck LLC | $28.08 | 2024 | Vyepti |
| Kowa Pharmaceuticals America, INC. | $28.00 | 2021 | |
| Amgen INC. | $25.77 | 2024 | Krystexxa |
| Pulmonx Corporation | $25.72 | 2024 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Edwards Lifesciences Corporation | $22.57 | 2022 | |
| Acadia Pharmaceuticals INC | $22.12 | 2025 | Nuplazid |
| Otsuka America Pharmaceutical, INC. | $21.90 | 2023 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $20.30 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.21 | 2022 | |
| Scilex Pharmaceuticals INC. | $20.10 | 2023 | Ztlido |
| Esperion Therapeutics, INC. | $19.51 | 2020 | |
| Avanir Pharmaceuticals, INC. | $17.47 | 2019 | |
| Abiomed | $16.78 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $16.47 | 2024 | Uptravi, Opsumit |
| Phathom Pharmaceuticals, INC. | $16.14 | 2024 | Voquezna |
| Upsher-Smith Laboratories LLC | $15.13 | 2021 | |
| Dexcom, INC. | $14.53 | 2023 | Dexcom G6 Transmitter |
| Inari Medical, INC. | $14.48 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Vistapharm, INC. | $12.43 | 2021 | |
| Shire North American Group INC | $11.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Mccullough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.